Trial Profile

International Active Surveillance Study of Medication Used for the Treatment of Endometriosis: Visanne Post-approval Observational Study.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dienogest (Primary) ; Danazol; Hormonal contraceptives; Hormones; Progesterone congeners
Indications Endometriosis
Focus Adverse reactions
Acronyms VIPOS

Most Recent Events

27 Jul 2020 Status changed from active, no longer recruiting to completed.
16 Apr 2020 Results of long-term follow-up analysis of clinical outcomes were published in the Advances in Therapy
10 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Nov 2018.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com